Published in World J Surg Oncol on July 07, 2016
Altered Mitochondrial Signalling and Metabolism in Cancer. Front Oncol (2017) 0.75
Cancer: Untethering Mitochondria from the Endoplasmic Reticulum? Front Oncol (2017) 0.75
Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res (2003) 103.76
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
The Database of Interacting Proteins: 2004 update. Nucleic Acids Res (2004) 23.67
Human Protein Reference Database--2009 update. Nucleic Acids Res (2008) 21.25
Hepatocellular carcinoma. N Engl J Med (2011) 19.40
PID: the Pathway Interaction Database. Nucleic Acids Res (2008) 12.92
The GTPase superfamily: a conserved switch for diverse cell functions. Nature (1990) 11.71
Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res (2010) 11.23
PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res (2012) 8.54
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet (2004) 7.45
The KEGG database. Novartis Found Symp (2002) 6.86
Cellular oncogenes and multistep carcinogenesis. Science (1983) 6.52
Dissecting p53 tumor suppressor functions in vivo. Cancer Cell (2002) 6.24
MINT, the molecular interaction database: 2012 update. Nucleic Acids Res (2011) 5.25
The MIntAct project--IntAct as a common curation platform for 11 molecular interaction databases. Nucleic Acids Res (2013) 4.39
The BioGRID interaction database: 2015 update. Nucleic Acids Res (2014) 4.06
Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem (2003) 3.45
Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo. J Cell Sci (2002) 3.42
Unequal evolutionary conservation of human protein interactions in interologous networks. Genome Biol (2007) 2.45
Phosphoinositide signalling in cancer: beyond PI3K and PTEN. Nat Rev Cancer (2010) 2.35
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer (2012) 2.10
Mitofusin-2 is a major determinant of oxidative stress-mediated heart muscle cell apoptosis. J Biol Chem (2007) 1.50
Subjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1{alpha}/Mitofusin-2 regulatory pathway in response to physical activity. Diabetes Care (2009) 1.42
Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway. Circ Res (2007) 1.39
ReactomeFIViz: the Reactome FI Cytoscape app for pathway and network-based data analysis. F1000Res (2014) 1.15
FAK is involved in invasion and metastasis of hepatocellular carcinoma. Clin Exp Metastasis (2010) 1.07
Adenovirus-expressed human hyperplasia suppressor gene induces apoptosis in cancer cells. Mol Cancer Ther (2008) 1.00
Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection. Proc Natl Acad Sci U S A (2013) 0.99
Pro-apoptotic and anti-proliferative effects of mitofusin-2 via Bax signaling in hepatocellular carcinoma cells. Med Oncol (2010) 0.98
Anti-tumor effects of Mfn2 in gastric cancer. Int J Mol Sci (2013) 0.97
Anti-tumour efficacy of mitofusin-2 in urinary bladder carcinoma. Med Oncol (2010) 0.97
Mitofusin-2 triggers mitochondria Ca2+ influx from the endoplasmic reticulum to induce apoptosis in hepatocellular carcinoma cells. Cancer Lett (2014) 0.96
MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma. Eur J Surg Oncol (2013) 0.91
Mitofusin-2 over-expresses and leads to dysregulation of cell cycle and cell invasion in lung adenocarcinoma. Med Oncol (2015) 0.91
Cytokine-induced tumor suppressors: a GRIM story. Cytokine (2010) 0.88
Mitofusin 2-deficiency suppresses cell proliferation through disturbance of autophagy. PLoS One (2015) 0.85
HSG provides antitumor efficacy on hepatocellular carcinoma both in vitro and in vivo. Oncol Rep (2010) 0.85
Mitofusin-2 is a novel direct target of p53. Biochem Biophys Res Commun (2010) 0.84
Rab31 promoted hepatocellular carcinoma (HCC) progression via inhibition of cell apoptosis induced by PI3K/AKT/Bcl-2/BAX pathway. Tumour Biol (2015) 0.82
Hepatitis B virus X protein inhibits p53-mediated upregulation of mitofusin-2 in hepatocellular carcinoma cells. Biochem Biophys Res Commun (2012) 0.80
Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways. Oncotarget (2016) 0.78
Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling. World J Gastroenterol (2016) 0.77
Biological features and biomarkers in hepatocellular carcinoma. World J Hepatol (2015) 0.76
Gene expression of key regulators of mitochondrial biogenesis is sex dependent in mice with growth hormone receptor deletion in liver. Aging (Albany NY) (2015) 0.76